2016
DOI: 10.1172/jci84652
|View full text |Cite
|
Sign up to set email alerts
|

CHD4-regulated plasmin activation impacts lymphovenous hemostasis and hepatic vascular integrity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
31
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 29 publications
(36 citation statements)
references
References 51 publications
0
31
1
Order By: Relevance
“…LYVE-1 protein is robustly expressed by LECs during normal mouse development, including in the jugular lymph sacs at E12.5, and is also detected at some level in lymph nodes, liver sinusoids, spleen sinuses, blood vessels, endocardium and a subpopulation of macrophages (Banerji et al, 1999; Baluk and McDonald, 2008; Gordon et al, 2008). The Lyve-1 Cre mouse line has been used by others to successfully inactivate, in a lymphatic-targeted manner, the genes encoding sphingosine kinase, VEGFR2, and the chromatin remodeling enzyme CHD4 (Pham et al, 2010; Dellinger et al, 2013; Crosswhite et al, 2016). Dellinger et al showed that Lyve-1 Cre can be used to delete floxed DNA sequences in LECs that generate collecting lymphatics and their valves, as well as lymphatic capillaries (Dellinger et al, 2013).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…LYVE-1 protein is robustly expressed by LECs during normal mouse development, including in the jugular lymph sacs at E12.5, and is also detected at some level in lymph nodes, liver sinusoids, spleen sinuses, blood vessels, endocardium and a subpopulation of macrophages (Banerji et al, 1999; Baluk and McDonald, 2008; Gordon et al, 2008). The Lyve-1 Cre mouse line has been used by others to successfully inactivate, in a lymphatic-targeted manner, the genes encoding sphingosine kinase, VEGFR2, and the chromatin remodeling enzyme CHD4 (Pham et al, 2010; Dellinger et al, 2013; Crosswhite et al, 2016). Dellinger et al showed that Lyve-1 Cre can be used to delete floxed DNA sequences in LECs that generate collecting lymphatics and their valves, as well as lymphatic capillaries (Dellinger et al, 2013).…”
Section: Resultsmentioning
confidence: 99%
“…Using the same Lyve-1 Cre allele, Crosswhite et. al showed that CHD4 is efficiently deleted from Lyve-1 Cre ; Chd4 fl/fl LECs by E14.5 (Crosswhite et al, 2016). LV formation in the mesenteric collecting lymphatics, which are derived from the LYVE-1 positive lymphatic capillaries, does not begin until E16.…”
Section: Discussionmentioning
confidence: 99%
“…Similar to STAB2, LYVE1 shows restricted vascular expression in LSECs, but LYVE1 is also known to be expressed by lymphatic endothelium as well as by HSCs and progenitor cells and by some macrophage populations (28). In Lyve1-Cre R26LacZ reporter mice, β-gal activity was predominantly found in LSECs (Supplemental Figure 5A).…”
Section: Genetic Inactivation Of Gata4 In the Hepatic Microvasculaturmentioning
confidence: 95%
“…We previously reported that excessive plasmin activation and subsequent ECM degradation cause embryonic vascular fragility . Embryonic hepatic sinusoidal blood vessels are particularly prone to rupture when their underlying laminin‐rich ECM is degraded by plasmin .…”
mentioning
confidence: 99%